|
419
|
| 1855 |
GPAM
|
|
affects_activity of
|
cell population proliferation
|
in liver
|
|
17258706
|
Diabetes mellitus, type II
Insulin resistance
|
|
530
|
| 2638 |
AMPK
|
|
affects_activity of
|
cell population proliferation
|
|
|
14511394
|
Diabetes mellitus, type II
Peutz-Jeghers syndrome
Insulin resistance
|
|
710
|
| 3964 |
WNT3A
|
|
increases_activity of
|
cell population proliferation
|
|
|
19591802
|
Parkinson disease
|
|
758
|
| 4272 |
PTN
|
|
affects_activity of
|
cell population proliferation
|
in the central nervous system
|
|
18727926
|
Neurological
|
|
855
|
| 5097 |
PARK7
|
|
increases_activity of
|
cell population proliferation
|
under starvation conditions
|
|
15766664
|
Breast cancer
Parkinson disease
|
|
900
|
| 5319 |
PRKN
|
|
decreases_activity of
|
cell population proliferation
|
in cancer cells
|
| 5322 |
PARK2-p.R42C
|
NOT |
decreases_activity of
|
cell population proliferation
|
in cancer cells
|
| 5326 |
PARK2-p.N254S
|
NOT |
decreases_activity of
|
cell population proliferation
|
in cancer cells
|
| 5327 |
PARK2-p.R275Q
|
NOT |
decreases_activity of
|
cell population proliferation
|
in cancer cells
|
| 5328 |
PARK2-p.E344G
|
NOT |
decreases_activity of
|
cell population proliferation
|
in cancer cells
|
|
19946270
|
Glioblastoma
Parkinson disease
|
|
941
|
| 5702 |
FOXA2
|
|
decreases_activity of
|
cell population proliferation
|
|
|
20049900
|
Neurological
Parkinson disease
|
|
1,330
|
| 9107 |
NGF
|
|
decreases_activity of
|
cell population proliferation
|
of Leukemia cells
|
|
19668232
|
Leukemia
Disease-related-protein CtBP
|
|
1,331
|
| 9117 |
CCNA1
|
|
increases_activity of
|
cell population proliferation
|
|
|
19668232
|
Leukemia
Disease-related-protein CtBP
|
|
1,901
|
| 14533 |
CEBPA
|
|
decreases_activity of
|
cell population proliferation
|
together with GIF1
|
|
20924107
|
Hematological
|
|
2,141
|
| 17820 |
AMPK
|
NOT |
affects_activity of
|
cell population proliferation
|
|
| 17823 |
RAS
|
|
affects_activity of
|
cell population proliferation
|
|
|
20018878
|
Diabetes mellitus, type II
Insulin resistance
|
|
2,373
|
| 20835 |
LEP
|
|
increases_activity of
|
cell population proliferation
|
proliferation of neuronal progenitors
|
|
21335656
|
Alzheimer disease
|
|
2,814
|
| 26036 |
MAPK3/1
|
|
increases_activity of
|
cell population proliferation
|
|
|
21912508
|
Diabetes mellitus, type II
Cancer
Insulin resistance
Metabolic syndrome
|
|
2,847
|
| 26237 |
Metformin
|
|
decreases_activity of
|
cell population proliferation
|
not via AMPK signaling pathway
|
|
18212742
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
|
2,848
|
| 26245 |
Metformin
|
|
decreases_activity of
|
cell population proliferation
|
|
|
19822355
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
|
2,849
|
| 26254 |
Metformin
|
|
decreases_activity of
|
cell population proliferation
|
|
|
17447005
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
|
2,897
|
| 26600 |
Metformin
|
|
decreases_activity of
|
cell population proliferation
|
|
|
19221498
|
Breast cancer
Diabetes mellitus, type II
Insulin resistance
|
|
2,904
|
| 26629 |
Metformin
|
|
decreases_activity of
|
cell population proliferation
|
|
|
17062558
|
Breast cancer
Diabetes mellitus, type II
Insulin resistance
|
|
2,911
|
| 26689 |
increased circulating insulin-like growth factor I level
|
|
increases_activity of
|
cell population proliferation
|
|
|
9354418
|
Diabetes mellitus, type II
Insulin resistance
|
|
2,984
|
| 27193 |
KLF11
|
|
decreases_activity of
|
cell population proliferation
|
via down-regulation of prostaglandin E2 biosynthesis
|
|
20154088
|
Diabetes mellitus, type II
Insulin resistance
|
|
3,344
|
| 30714 |
CRHR1
|
|
increases_activity of
|
cell population proliferation
|
|
| 30715 |
GHRHR
|
|
increases_activity of
|
cell population proliferation
|
|
|
21825133
|
Diabetes mellitus, type II
Insulin resistance
|
|
3,363
|
| 30875 |
Thiamazole
|
|
affects_activity of
|
cell population proliferation
|
in the hippocampal dentate gyrus
|
|
21212858
|
Diabetes mellitus, type II
Insulin resistance
Hypothyroidism
|
|
3,552
|
| 33003 |
Ibuprofen
|
|
increases_activity of
|
cell population proliferation
|
Ibuprofen can rescue decreased adult hippocampal cell proliferation.
|
|
20689579
|
Alzheimer disease
|
|
3,922
|
| 39809 |
Genistein
|
|
decreases_activity of
|
cell population proliferation
|
in MCF-7 breast cancer cells
|
| 39810 |
Docosahexaenoic acid
|
|
decreases_activity of
|
cell population proliferation
|
in MCF-7 breast cancer cells
|
| 39823 |
Eicosapentaenoic acid
|
|
decreases_activity of
|
cell population proliferation
|
in MCF-7 breast cancer cells
|
|
15914273
|
Diabetes mellitus, type II
Insulin resistance
|
|
4,309
|
| 44192 |
PDCD4
|
|
decreases_activity of
|
cell population proliferation
|
in H9 cells
|
| 44194 |
CCNG2
|
|
decreases_activity of
|
cell population proliferation
|
in H9 cells
|
|
19416884
|
Metabolic
|
|
4,717
|
| 46750 |
CRP
|
|
decreases_activity of
|
cell population proliferation
|
|
|
22301267
|
Cardiovascular disease
|
|
4,843
|
| 47840 |
FGF7
|
|
increases_activity of
|
cell population proliferation
|
|
|
16162944
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,182
|
| 50737 |
OxLDL
|
|
increases_activity of
|
cell population proliferation
|
of endothelial cells; via increasing the level of O2-
|
| 50742 |
Lysophosphatidylcholine
|
|
increases_activity of
|
cell population proliferation
|
of endothelial cells; via increasing the level of O2-
|
| 50743 |
O2-
|
|
increases_activity of
|
cell population proliferation
|
of endothelial cells
|
|
11004212
|
Metabolic
Cardiovascular disease
|
|
5,232
|
| 50954 |
Quercetin
|
|
decreases_activity of
|
cell population proliferation
|
|
| 50955 |
Ursolic acid
|
|
decreases_activity of
|
cell population proliferation
|
|
| 50959 |
Rutin
|
NOT |
affects_activity of
|
cell population proliferation
|
|
|
18276086
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,253
|
| 51214 |
CYP1A1
|
|
increases_activity of
|
cell population proliferation
|
in MCF-7 and MDA-MB-231 breast cancer cell lines
|
|
23576571
|
Breast cancer
Diabetes mellitus, type II
Insulin resistance
|
CIDeRplus